ATE378408T1 - Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren - Google Patents
Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetierenInfo
- Publication number
- ATE378408T1 ATE378408T1 AT99969114T AT99969114T ATE378408T1 AT E378408 T1 ATE378408 T1 AT E378408T1 AT 99969114 T AT99969114 T AT 99969114T AT 99969114 T AT99969114 T AT 99969114T AT E378408 T1 ATE378408 T1 AT E378408T1
- Authority
- AT
- Austria
- Prior art keywords
- seq
- ztgfss9
- mammal
- growth factor
- transforming growth
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title 1
- 102000009618 Transforming Growth Factors Human genes 0.000 title 1
- 108010009583 Transforming Growth Factors Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15481798A | 1998-09-17 | 1998-09-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE378408T1 true ATE378408T1 (de) | 2007-11-15 |
Family
ID=22552920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99969114T ATE378408T1 (de) | 1998-09-17 | 1999-09-17 | Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren |
Country Status (11)
| Country | Link |
|---|---|
| EP (2) | EP1114156B1 (de) |
| JP (2) | JP2002525056A (de) |
| AT (1) | ATE378408T1 (de) |
| AU (1) | AU6050499A (de) |
| CA (2) | CA2343569C (de) |
| DE (1) | DE69937570T2 (de) |
| DK (1) | DK1114156T3 (de) |
| ES (1) | ES2300154T3 (de) |
| IL (1) | IL141869A0 (de) |
| WO (1) | WO2000015798A2 (de) |
| ZA (1) | ZA200101819B (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6562578B1 (en) | 1999-01-11 | 2003-05-13 | Schering Corporation | IL-17-like cytokine binding compounds and antibodies |
| JP3577586B2 (ja) | 1998-05-15 | 2004-10-13 | ジェネンテック・インコーポレーテッド | Ｉｌ−１７相同的ポリペプチドとその治療用途 |
| US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
| EP1443055A3 (de) * | 1998-05-29 | 2005-06-08 | Human Genome Sciences, Inc. | Interleukine-21 und 22 |
| PT1141297E (pt) * | 1999-01-11 | 2010-01-06 | Schering Corp | Citoquinas de mamíferos relacionadas com a interleucina-17. polinucleótidos que as codificam. utilizações |
| EP1897943B1 (de) * | 1999-12-23 | 2011-12-14 | Genentech, Inc. | IL-17-homologe Polypeptide und ihre therapeutische Verwendung |
| US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
| US20030166268A1 (en) * | 2000-05-31 | 2003-09-04 | Holloway James L. | Mammalian transforming growth factor beta-10 |
| US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| CA2430257A1 (en) * | 2000-11-28 | 2002-06-06 | Amgen, Inc. | Transforming growth factor-beta-related molecules and uses thereof |
| ES2360481T3 (es) | 2001-01-25 | 2011-06-06 | Zymogenetics, Inc. | Procedimiento para tratar psoriasis usando un antagonista de il- 17d. |
| WO2003004527A2 (en) * | 2001-07-06 | 2003-01-16 | Nsgene A/S | Novel neurotrophic factors |
| GB0417487D0 (en) | 2004-08-05 | 2004-09-08 | Novartis Ag | Organic compound |
| EP2094725A1 (de) * | 2006-11-08 | 2009-09-02 | ZymoGenetics, Inc. | Varianten und verfahren zur anwendung des transforming growth factor beta-9 |
| KR20150002874A (ko) | 2008-05-05 | 2015-01-07 | 노비뮨 에스 에이 | 항-ｉｌ-１７ａ／ｉｌ-１７ｆ 교차-반응성 항체 및 그의 사용 방법 |
| US8137671B2 (en) | 2009-05-05 | 2012-03-20 | Genentech, Inc. | Anti-IL-17F antibodies |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5532159A (en) * | 1994-04-01 | 1996-07-02 | The Ohio State University | Monoclonal antibody to canine placental oncofetal protein for detecting cancer |
| EP0839196B1 (de) * | 1995-07-19 | 2005-05-11 | Genetics Institute, LLC | Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen |
| BR9809778A (pt) * | 1997-04-25 | 2000-06-20 | Zymogenetics Inc | Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico. |
| AU4208799A (en) | 1998-05-29 | 1999-12-13 | Human Genome Sciences, Inc. | Interleukins-21 and 22 |
| PT1141297E (pt) | 1999-01-11 | 2010-01-06 | Schering Corp | Citoquinas de mamíferos relacionadas com a interleucina-17. polinucleótidos que as codificam. utilizações |
-
1999
- 1999-09-17 DK DK99969114T patent/DK1114156T3/da active
- 1999-09-17 EP EP99969114A patent/EP1114156B1/de not_active Expired - Lifetime
- 1999-09-17 WO PCT/US1999/021677 patent/WO2000015798A2/en not_active Ceased
- 1999-09-17 EP EP07017934A patent/EP1897948A1/de not_active Withdrawn
- 1999-09-17 AT AT99969114T patent/ATE378408T1/de active
- 1999-09-17 IL IL14186999A patent/IL141869A0/xx unknown
- 1999-09-17 AU AU60504/99A patent/AU6050499A/en not_active Abandoned
- 1999-09-17 ES ES99969114T patent/ES2300154T3/es not_active Expired - Lifetime
- 1999-09-17 CA CA2343569A patent/CA2343569C/en not_active Expired - Fee Related
- 1999-09-17 JP JP2000570325A patent/JP2002525056A/ja not_active Withdrawn
- 1999-09-17 DE DE69937570T patent/DE69937570T2/de not_active Expired - Lifetime
- 1999-09-17 CA CA2706859A patent/CA2706859A1/en not_active Abandoned
-
2001
- 2001-03-05 ZA ZA200101819A patent/ZA200101819B/en unknown
-
2010
- 2010-04-22 JP JP2010098890A patent/JP2010187691A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| DE69937570D1 (de) | 2007-12-27 |
| ZA200101819B (en) | 2001-09-27 |
| WO2000015798A3 (en) | 2000-05-25 |
| EP1114156B1 (de) | 2007-11-14 |
| CA2706859A1 (en) | 2000-03-23 |
| DE69937570T2 (de) | 2009-04-23 |
| EP1897948A1 (de) | 2008-03-12 |
| IL141869A0 (en) | 2002-03-10 |
| CA2343569C (en) | 2010-09-14 |
| AU6050499A (en) | 2000-04-03 |
| EP1114156A2 (de) | 2001-07-11 |
| JP2010187691A (ja) | 2010-09-02 |
| WO2000015798A2 (en) | 2000-03-23 |
| DK1114156T3 (da) | 2008-03-03 |
| JP2002525056A (ja) | 2002-08-13 |
| ES2300154T3 (es) | 2008-06-01 |
| CA2343569A1 (en) | 2000-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE378408T1 (de) | Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren | |
| DK0839196T3 (da) | Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner | |
| IL210455A0 (en) | Novel cytokine zcytor17 ligand | |
| ATE269902T1 (de) | Cytokinähnliches polypeptid-10 aus säugetieren | |
| ATE360696T1 (de) | Interferon-ähnliches protein zcyto21 | |
| DE60329070D1 (de) | Antikörper gegen den fibroblastenwachstumsfaktor 23 | |
| ATE536409T1 (de) | Unkrautbekämpfungsstoffwechselproteine, gene dafür und ihre verwendung | |
| EA201001190A1 (ru) | Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков | |
| GR3023593T3 (en) | Protein structure of the plant toxin gelonin | |
| CY1111763T1 (el) | ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51 | |
| DE69929454D1 (de) | Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen | |
| DK0773999T3 (da) | OR-1, en orphan-receptor tilhørende kernereceptorfamilien | |
| EA200100440A1 (ru) | Ген prv-1 и его применение | |
| EP1295943A4 (de) | Polypeptide mit aktivität der stimulierung von neutrophilen | |
| NZ606260A (en) | Novel polypeptides involved in immune response |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1114156 Country of ref document: EP |